Pay in 4 interest-free payments of $5.85 Learn more
Ships within 48 hours · Estimated delivery Oct 11 - Oct 16
A study presented at the 2024 European Academy of Allergy and Clinical Immunology Congress examined the prevalence of GLP-1 discontinuation amongst newly prescribed T2D and patients who are obese and the characteristics associated with discontinuation
Dispose of the syringe and needle in a Sharps Container
Schedules vary by protocol
In summary, the 15 mg dose offers the strongest average therapeutic effect, but many patients achieve excellent results on middle doses (5 mg or 10 mg)
A study by T
US$ 23.13
US$ 25.55
US$ 29.23
US$ 29.32
US$ 28.53
